Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: J Pediatr Gastroenterol Nutr. 2021 Jun 1;72(6):848–853. doi: 10.1097/MPG.0000000000003089

Table 2:

Coexisting Diagnoses

Child n=112 Adolescent n=127 P Value Male n=71 Female n=168 P Value
Gastroesophageal reflux disease 53 (47.3)# 58 (45.7) 0.80 41 (57.7) 70 (41.7) 0.023
Migraines 11 (9.8) 25 (19.7) 0.03 4 (5.6) 32 (19) 0.008
Autism or Developmental Delay 13 (11.6) 10 (7.9) 0.34 14 (19.7) 9 (5.4) 0.001
Prematurity 12 (10.7) 5 (3.9) 0.04 9 (12.7) 8 (4.8) 0.03
POTS*/dysautonomia 3 (2.7) 14 (11.0) 0.01 1 (1.4) 16 (9.5) 0.027
Eosinophilic Digestive Disease 7 (6.3) 9 (7.1) 0.78 4 (5.6) 12 (7.1) 0.78
Lactose Intolerance 7 (6.3) 8 (6.3) 0.99 4 (5.6) 11 (6.5) 1.00
Ehlers Danlos Syndrome 7 (6.3) 8 (6.3) 0.99 3 (4.2) 12 (7.1) 0.56
Chromosomal Abnormality 7 (6.3) 6 (4.7) 0.60 7 (9.9) 6 (3.6) 0.05
Rumination 6 (5.4) 5 (3.9) 0.41 7 (9.9) 4 (2.4) 0.018
H. pylori 1 (0.9) 8 (6.3) 0.03 0 9 (5.4) 0.047
History of Fundoplication 3 (2.7) 4 (3.1) 0.57 4 (5.6) 3 (1.8) 0.2
Diabetes Mellitus 1 (0.9) 2 (1.6) 0.55 0 3 (1.3) 0.56
#

Percent

*

Postural orthostatic tachycardia syndrome